Elizabeth Rozek serves as Executive at Sagimet Biosciences Inc., where they oversee executive responsibilities. Since joining the company, Elizabeth Rozek has executed 4 insider transactions totaling $132.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 4, 2025 involved receiving (via award) 9,855 shares valued at $0.
Elizabeth Rozek currently holds 193,581 shares of Sagimet Biosciences Inc. (SGMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth Rozek has been a net seller of SGMT stock. They have purchased $0 and sold $132.3K worth of shares.
Elizabeth Rozek's most recent insider trade was on Nov 4, 2025, when they sold 9,855 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $9.13 |
| Discretionary |
| Jul 19, 2024 | SGMT | $33.8K | Sale | 10,914 | $3.10 | Discretionary |
| Nov 17, 2023 | SGMT | $0 | Award | 171,420 | $N/A | Discretionary |